Northwestern Mutual Wealth Management
RYTM icon

Northwestern Mutual Wealth Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-48
Closed -$2.54K – 3952
2025
Q1 		$2.54K Buy
+48
New +$2.66K ﹤0.01% 3096
2024
Q1 		– Sell
-1,250
Closed -$57.5K – 3777
2023
Q4 		$57.5K Buy
+1,250
New +$39.4K ﹤0.01% 1996

Other funds holding RYTM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northwestern Mutual Wealth Management's RYTM Position: Q2 2025 in Review

Northwestern Mutual Wealth Management sold out of Rhythm Pharmaceuticals (RYTM) in Q2 2025, closing a stake of 48 shares — an estimated $2.54K sold.

Northwestern Mutual Wealth Management first reported a position in RYTM in Q4 2023 and held it in 2 quarters. The position peaked at $57.5K in Q4 2023. 227 funds tracked by Wall St. Rank hold RYTM as of Q2 2025.

  • Northwestern Mutual Wealth Management reported no remaining Rhythm Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 48 Rhythm Pharmaceuticals shares in Q2 2025, an estimated $2.54K.
  • Northwestern Mutual Wealth Management first reported a position in Rhythm Pharmaceuticals in Q4 2023 and held it in 2 quarters.
  • Northwestern Mutual Wealth Management's Rhythm Pharmaceuticals position peaked at $57.5K in Q4 2023.
  • 227 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2025.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.